FDA Approves Bemotrizinol, First New Sunscreen Ingredient in Two Decades
By
Veronique Greenwood
Plain bagel done well. Pleasantly substantive.
Summary
The FDA has approved bemotrizinol, the first new sunscreen ingredient in the U.S. in 20 years. This broad-spectrum UV blocker has been used in Europe and other countries for years but was previously unavailable in American sunscreens due to the FDA's classification of sunscreen ingredients as drugs rather than cosmetics, which has slowed approval processes compared to other nations.
Key quotes
· 3 pulledBemotrizinol is a powerful, broad-spectrum blocker of dangerous rays that has been used in Europe and other parts of the world for years
The U.S. has been far slower than other countries to approve new sunscreen ingredients
They are treated as drugs in the U.S.—not as cosmetics
You might also wanna read

Why Better Sunscreen Is Finally on the Way to the U.S.
Australia's Sunscreen Protection Scandal Raises Concerns in Skin Cancer Capital
Australia is facing a major sunscreen scandal that has shaken consumer trust in the country with the world's highest skin cancer rates. The
FDA Approves First 100% Effective HIV Prevention Drug with Global Impact
The article discusses the milestone approval of the first HIV prevention drug, lenacapavir (brand name Yeztugo), which offers 100% protectio
Consumer Council Finds Over 80% of Sunscreens Tested Fall Short of Labelled SPF and UVA Protection Claims
The Consumer Council tested 30 sunscreen models and found that over 80% performed below their labelled efficacy. 4 models had measured SPF b

The Best Tinted Sunscreens for Glowing, Protected Skin All Summer Long
FDA Approves First Non-Opioid Pain Reliever: Journavx by Vertex Pharmaceuticals
The FDA approved Vertex Pharmaceuticals's Journavx (suzetrigine) in January 2025, marking the first non-opioid pain reliever.
